This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

UK startups amongst those selected for world's largest medtech accelerator program

MedTech Innovator yesterday announced the 50 med-tech companies that have been selected to be a part of their four-month accelerator program. Amongst those chosen are UK based companies 52 North Health, Oxford Endovascular and Phagenesis, as well as companies from the US, Canada, France, Germany, Israel, Ireland, Luxembourg and Singapore. 

The accelerator program, which aims to improve the lives of patients by accelerating the growth of companies that are involved in the transformation of the healthcare system, provides individualised mentorship and feedback, funding opportunities and other support, including IP advice, to early and mid-stage startups, with the ultimate winner getting a grand prize of $350,000 and the title of 2022 MedTech Innovator. 

It is great to see such a diverse selection of startups selected for the program and it will be interesting to see who the winner is when this is announced in October 2022!

"Over the past nine years, MedTech Innovator has established a unique track record of identifying and supporting leading startups, with 95% of our graduates either still in business or having been acquired," said Paul Grand, CEO of MedTech Innovator. "The 2022 MedTech Innovator Cohort represents a diverse and focused group of innovators, and we are excited to work with them alongside our corporate partners and industry advisors to ensure their success in addressing important unmet needs and improving patient care."


medical technologies, start-ups & spin-outs